TABLE 1.
Gastric cancer detection | |||||||
---|---|---|---|---|---|---|---|
Type of biomarker | BiomarkerRef. | Expression in GC | AUC (95% CI) | p‐value | Sensitivity (%) | Specificity (%) | With validation |
Saliva | |||||||
Lectins | AAL 20 | ↓ | 0.98 (0.97–1.00) | <0.001 | 92.0 | 95.0 | No |
ECA 20 | ↑ | 0.86 (0.80–0.93) | <0.001 | 72.0 | 88.0 | No | |
VVA 20 | ↑ | 0.96 (0.93–0.99) | <0.001 | 85.0 | 94.0 | No | |
RNA | mRNA PPL 21 | ↓ | 0.72 | NA | 63.0 | 64.0 | Validation set |
miR‐140‐5p 25 | ↓ | 0.70 (0.64–0.78) | NA | NA | NA | Validation set | |
Proteins | CSTB 27 | ↓ | 0.73 (0.60–0.83) | 0.002 | 83.9 | 71.0 | No |
DMBT1 27 | ↑ | 0.74 (0.61–0.84) | <0.001 | 80.7 | 64.5 | No | |
ModelsRef. | |||||||
10 amino acids SERS spectra bands 16 | NA | NA | 94.8 | 90.2 | No | ||
Bacterial genera 18 | 0.91 (0.78–0.99) | NA | NA | NA | CV | ||
2 lectins (SBA and VVA) 20 | 0.89 (0.80–0.99) | <0.001 | 96.0 | 80.0 | Validation set | ||
3 mRNAs and 2 miRNAs a 25 | 0.81 (0.72–0.89) | NA | 75.0 | 83.0 | Validation set | ||
3 mRNAs, 2 miRNAs a and demographic factors 25 | 0.87 (0.80–0.93) | NA | 82.0 | 77.0 | Validation set | ||
3 proteins (CSTB, TPI1, DMBT1) 26 | 0.93 | NA | 85.0 | 80.0 | Pre‐validation | ||
Oral swab | |||||||
Oral microbiota (13 OTUs) 23 | 0.82 (0.73–0.92) | NA | NA | NA | Pre‐validation | ||
Tongue coating | |||||||
6 bacterial genera b 28 | 0.88 (0.80–0.95) | NA | NA | NA | Pre‐validation |
Atrophic gastritis detection | |||||||
---|---|---|---|---|---|---|---|
Type of biomarker | BiomarkerRef. | Expression in GC | AUC (95% CI) | p‐value | Sensitivity (%) | Specificity (%) | With validation |
Saliva | |||||||
Lectins | DSA 20 | ↓ | 0.97 (0.95–1.00) | < 0.001 | 87.0 | 96.0 | No |
LEL 20 | ↑ | 0.96 (0.93–1.00) | < 0.001 | 93.0 | 92.0 | No | |
VVA 20 | ↑ | 0.81 (0.71–0.91) | <0.001 | 70.0 | 91.0 | Validation set | |
ModelsRef. | |||||||
Bacterial genera 18 | 0.76 | NA | NA | NA | CV | ||
2 lectins (DSA and VVA) 20 | 0.83 (0.71–0.94) | <0.001 | 70.0 | 91.0 | Validation set |
Note: Only molecules with reported relative abundance and reaching AUC >0.70 were included (suggested by 38 as moderate accuracy). In bold are AUC values > 0.90. Pre‐validation means the biomarkers have been validated using the same population, whereas CV is a resampling validation technique that tests and trains a model using different portions of the data.
Abbreviations: AUC, area under the receiver operating characteristic (ROC) curve; CI, confidence interval; CV, cross‐validation; GC, gastric cancer; OTU, operational taxonomic units.
SPINK7, PPL, SEMA4B, miR‐140‐5p, and miR‐301a.
Fusobacterium, Peptococcus, Peptostreptococcus, Porphyromonas, Megamonas, and Rothia.